Cargando…

C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis

The CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP), a major transcriptional regulator of endoplasmic reticulum (ER) stress-mediated apoptosis, is implicated in lipotoxicity-induced ER stress and hepatocyte apoptosis in non-alcoholic fatty liver disease (NAFLD). We have previously d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahman, Khalidur, Liu, Yunshan, Kumar, Pradeep, Smith, Tekla, Thorn, Natalie E., Farris, Alton B., Anania, Frank A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965279/ https://www.ncbi.nlm.nih.gov/pubmed/27239734 http://dx.doi.org/10.1038/labinvest.2016.61

Ejemplares similares

Adiponectin Agonist ADP355 Attenuates CCl(4)-Induced Liver Fibrosis in Mice
por: Kumar, Pradeep, et al.
Publicado: (2014)

Dysregulation of junctional adhesion molecule‐A contributes to ethanol‐induced barrier disruption in intestinal epithelial cell monolayers
por: Chopyk, Daniel M., et al.
Publicado: (2017)

Free Cysteine Modulates the Conformation of Human C/EBP Homologous Protein
por: Singh, Vinay K., et al.
Publicado: (2012)

Treatment of an Adolescent Female With Nonalcoholic Steatohepatitis–Related Cirrhosis With Liraglutide
por: Yuen, Christina, et al.
Publicado: (2023)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Liraglutide Attenuates Hepatic Ischemia–Reperfusion Injury by Modulating Macrophage Polarization
por: Li, Shang-Lin, et al.
Publicado: (2022)

Transcription Factor C/EBP Homologous Protein in Health and Diseases
por: Yang, Yuan, et al.
Publicado: (2017)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
por: Liu, Yu, et al.
Publicado: (2021)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
por: Armstrong, Matthew J, et al.
Publicado: (2013)

The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
por: Vallöf, Daniel, et al.
Publicado: (2015)

C/EBP homologous protein drives pro-catabolic responses in chondrocytes
por: Husa, Matt, et al.
Publicado: (2013)

IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
por: Mas, Emmanuel, et al.
Publicado: (2009)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C/EBPδ signalling activation
por: Xu, Minxuan, et al.
Publicado: (2023)

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
por: Yang, Mengying, et al.
Publicado: (2020)

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Wu, Jingyi, et al.
Publicado: (2023)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
por: Cabrera, Daniel, et al.
Publicado: (2017)

Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis
por: Tsukahara, Yuko, et al.
Publicado: (2022)

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
por: Macias, Juan, et al.
Publicado: (2022)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH)
por: Min-DeBartolo, Jessica, et al.
Publicado: (2019)

Modulating hepatic macrophages with annexin A1 in non-alcoholic steatohepatitis
por: De Ponti, Federico F., et al.
Publicado: (2022)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Frontiers Production Office,
Publicado: (2023)

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
por: Yang, Chao, et al.
Publicado: (2021)

Deficiency of CD147 Attenuated Non-alcoholic Steatohepatitis Progression in an NLRP3-Dependent Manner
por: Zhang, Tian, et al.
Publicado: (2020)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
por: Luo, Ying, et al.
Publicado: (2019)

SUN-694 Case Study of Nonalcoholic Steatohepatitis Reversibility in Type Two Diabetic Patient with Weight Loss Using Liraglutide
por: Shaghouli, Amna Ali, et al.
Publicado: (2020)

The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials
por: Malik, Adnan, et al.
Publicado: (2022)

Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms
por: El-Derany, Marwa O., et al.
Publicado: (2022)

C/EBP homologous protein (CHOP) mediates neuronal apoptosis in rats with spinal cord injury
por: WANG, ZHANGFU, et al.
Publicado: (2013)

Redundant Functions of ERK1 and ERK2 Maintain Mouse Liver Homeostasis Through Down‐Regulation of Bile Acid Synthesis
por: Cingolani, Francesca, et al.
Publicado: (2021)

Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity
por: Mulder, P, et al.
Publicado: (2016)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021)

Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis
por: Kuroda, Hidekatsu, et al.
Publicado: (2021)

Celecoxib-mediated attenuation of non-alcoholic steatohepatitis is potentially relevant to redistributing the expression of adiponectin receptors in rats
por: Zhu, Guoying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qnc1sdbtn0qb1l0rmi2ik2rto